These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Teva, Viatris win new chance to challenge J&J schizophrenia drug patent
Teva Pharmaceutical and Viatris convinced a U.S. appeals court on Monday to revive their challenges to a patent covering a blockbuster Johnson & Johnson schizophrenia drug, giving them a new chance...
Procter & Gamble, Johnson & Johnson Among 10 Dividend Growth Companies Announcing Increases In First Half Of April
Procter & Gamble, Johnson & Johnson Among 10 Dividend Growth Companies Announcing Increases In First Half Of April
With Lawsuit And Medtech Tailwinds - Johnson & Johnson May Be Back
Johnson & Johnson settles a consumer protection lawsuit for $75 million, a significant reduction from the initial demand of $6 billion. The company is facing nearly 60,000 lawsuits from ex-talc use...
Final Trades: JNJ, M, IYH & CLF
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Shockwave Medical rallies as J&J mulls purchase
Shockwave Medical shares are trading more than 3% higher in Wednesday's session, having soared more than 10% since it was announced Johnson & Johnson (NYSE:JNJ) was considering buying it. The maker...
Why the Market Dipped But Johnson & Johnson (JNJ) Gained Today
In the latest trading session, Johnson & Johnson (JNJ) closed at $155.77, marking a +0.35% move from the previous day.
Shockwave Medical shares rise on report of acquisition talks with Johnson & Johnson
Shares of medical-device maker Shockwave Medical Inc. rose Tuesday following a report that Johnson & Johnson was in talks to acquire the company.
Johnson & Johnson considers deal to buy Shockwave Medical, WSJ reports
Johnson & Johnson is in talks to buy medical device maker Shockwave Medical , the Wall Street Journal reported on Tuesday.
7 Dividend Darlings to Scoop Up Every Time the Market Dips
Dividend investing is one of the prominent ways to build wealth. Whether you are building a retirement portfolio, want to leave a legacy, or are looking to use the dividend income to cover your exp...
Johnson & Johnson (JNJ), Nvidia Unite to Boost AI for Surgery
Johnson & Johnson (JNJ) collaborates with Nvidia to facilitate the creation of AI-based models and the deployment of applications, offering a route to scale within its digital ecosystem for surgery.
Will Johnson & Johnson Stock Rebound To Its Pre-Inflation Shock Highs Of $185?
Johnson & Johnson (NYSE: JNJ) currently trades around $160 per share, 15% below its peak level of over $185 seen in April 2022, and it seems like it can see higher levels over time. JNJ stock was t...
Johnson & Johnson (JNJ) Stock Dips While Market Gains: Key Facts
Johnson & Johnson (JNJ) closed the most recent trading day at $156.76, moving -0.9% from the previous trading session.
Nvidia and Johnson & Johnson to develop new AI applications for surgery
Johnson & Johnson MedTech and Nvidia are developing new artificial intelligence applications for surgery.
J&J (JNJ) Gets FDA Panel Vote for Carvykti's Expanded Use
J&J (JNJ) is looking for expansion of Carvykti's label for the treatment of adult patients with relapsed and lenalidomide-refractory multiple myeloma.
Related Companies